Background: The multi-disciplinary tumor board (MTB) is essential to quality cancer care and currently recommended to offer the best personalized clinical approach, but little has been published regarding MTBs in neuro-oncology (nMTBs). The aim of the present paper is to describe our nMTB, to evaluate its impact on clinical management decisions, and to assess the role of neuroradiologists. Methods: The retrospective evaluation of the cases discussed at our nMTB from March 2017 to March 2020. From the electronic records, we extracted epidemiological, clinical and other specific data of nMTB. From the radiological records, we calculated data relating to the number, time for revision, and other specifications of MRI re-evaluation. Statistical analysis was performed. Results: a total of 447 discussions were analyzed, representing 342 patients. The requests for case evaluations came from radiation oncologists (58.8%) and neurosurgeons (40.5%), and were mainly addressed to the neuroradiologist (73.8%). The most frequent questions were about the treatment's changes (64.4%). The change in patient treatment was reported in 40.5% of cases, 76.8% of these were based on the neuroradiologic assessment. A total of 1514 MRI examinations were re-evaluated, employing approximately 67 h overall. The median of the MRI exams reviewed per patient was 3 (min-max 1-12). Conclusions: Our study supported that the multidisciplinary approach to patient care can be particularly effective in managing brain tumors. A review by an expert neuroradiologist impacts patient management in the context of nMTBs, but has costs in terms of the time and effort spent preparing for it.

Gaudino, S., Giordano, C., Magnani, F., Cottonaro, S., Infante, A., Sabatino, G., La Rocca Giuseppe Maria Della Pepa, G., D'Alessandris, Q. G., Pallini, R., Olivi, A., Balducci, M., Chiesa, S., Gessi, M., Guadalupi, P., Russo, R., Schiarelli, C., Ausili Cefaro, L., Di Lella, G. M., Colosimo, C., Neuro-Oncology Multidisciplinary Tumor Board: The Point of View of the Neuroradiologist, <<JOURNAL OF PERSONALIZED MEDICINE>>, 2022; Jan 20 (12(2)): N/A-N/A. [doi:10.3390/jpm12020135] [http://hdl.handle.net/10807/201146]

Neuro-Oncology Multidisciplinary Tumor Board: The Point of View of the Neuroradiologist

Gaudino, Simona
Primo
Conceptualization
;
Giordano, Carolina
Secondo
Methodology
;
Magnani, Francesca
Investigation
;
Sabatino, Giovanni
Writing – Original Draft Preparation
;
D'Alessandris, Quintino Giorgio
Resources
;
Pallini, Roberto
Data Curation
;
Olivi, Alessandro
Writing – Review & Editing
;
Balducci, Mario
Membro del Collaboration Group
;
Chiesa, Silvia
Membro del Collaboration Group
;
Gessi, Marco
Membro del Collaboration Group
;
Russo, Rosellina
Membro del Collaboration Group
;
Schiarelli, Chiara
Membro del Collaboration Group
;
Ausili Cefaro, Luca
Membro del Collaboration Group
;
Di Lella, Giuseppe Maria
Penultimo
Membro del Collaboration Group
;
Colosimo, Cesare
Ultimo
Supervision
2022

Abstract

Background: The multi-disciplinary tumor board (MTB) is essential to quality cancer care and currently recommended to offer the best personalized clinical approach, but little has been published regarding MTBs in neuro-oncology (nMTBs). The aim of the present paper is to describe our nMTB, to evaluate its impact on clinical management decisions, and to assess the role of neuroradiologists. Methods: The retrospective evaluation of the cases discussed at our nMTB from March 2017 to March 2020. From the electronic records, we extracted epidemiological, clinical and other specific data of nMTB. From the radiological records, we calculated data relating to the number, time for revision, and other specifications of MRI re-evaluation. Statistical analysis was performed. Results: a total of 447 discussions were analyzed, representing 342 patients. The requests for case evaluations came from radiation oncologists (58.8%) and neurosurgeons (40.5%), and were mainly addressed to the neuroradiologist (73.8%). The most frequent questions were about the treatment's changes (64.4%). The change in patient treatment was reported in 40.5% of cases, 76.8% of these were based on the neuroradiologic assessment. A total of 1514 MRI examinations were re-evaluated, employing approximately 67 h overall. The median of the MRI exams reviewed per patient was 3 (min-max 1-12). Conclusions: Our study supported that the multidisciplinary approach to patient care can be particularly effective in managing brain tumors. A review by an expert neuroradiologist impacts patient management in the context of nMTBs, but has costs in terms of the time and effort spent preparing for it.
2022
Inglese
Gaudino, S., Giordano, C., Magnani, F., Cottonaro, S., Infante, A., Sabatino, G., La Rocca Giuseppe Maria Della Pepa, G., D'Alessandris, Q. G., Pallini, R., Olivi, A., Balducci, M., Chiesa, S., Gessi, M., Guadalupi, P., Russo, R., Schiarelli, C., Ausili Cefaro, L., Di Lella, G. M., Colosimo, C., Neuro-Oncology Multidisciplinary Tumor Board: The Point of View of the Neuroradiologist, <<JOURNAL OF PERSONALIZED MEDICINE>>, 2022; Jan 20 (12(2)): N/A-N/A. [doi:10.3390/jpm12020135] [http://hdl.handle.net/10807/201146]
File in questo prodotto:
File Dimensione Formato  
jpm-12-00135.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 1.28 MB
Formato Adobe PDF
1.28 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/201146
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact